Recon: Moderna to layoff 10% of staff; Trump pressures drugmakers to cut US prices

• NIH is shrinking the number of research projects it funds due to a new Trump policy (STAT)
• FDA chief says NIH ‘brewed up a virus that killed 20 million people’ (The Hill)
• Senate confirms Trump nominee to lead CDC (The Hill)
• Trump drove firing of FDA official (Politico)
• Inside the fall of Vinay Prasad at the FDA (STAT)
• US vaccination rates for measles, other diseases drop further, government data says (Reuters)
• Trump pressures 17 pharma CEOs to cut US drug prices (Reuters) (Bloomberg)
• Trump administration proposes pilot initiative to address controversy over 340B drug discount program (STAT)

• Canada has 3 times as many measles cases as US (The Hill)
• Ignoring China's biotech industry is no longer an option. It's a recipe for disaster (Endpoints)
• Neuralink Launches Clinical Trial in Britain to Test Brain Chip (Bloomberg)
• India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand (Reuters)

• Weight loss drugs may boost testosterone in men, study finds (The Hill)
• Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment (STAT)
• Alnylam raises revenue outlook as heart drug sees quick uptake (STAT)
• Moderna lays off 10% of workforce in further cost-cutting move (STAT) (Reuters)
• With $1.3 billion in hand, VC firm Frazier remains bullish on biotech (STAT)
• Using mRNA, scientists overcome a key challenge to HIV vaccines (STAT)
• AbbVie again hikes guidance as it eyes neuro, obesity and PD-1xVEGF deals (Endpoints)
• Bristol Myers raises revenue guidance for the year, prepares for major Cobenfy readouts (Endpoints)
• Fiat Heir Elkann Ditches Trucks for Bytes, Brands and Biotech (Bloomberg)
• Cigna's health services business powers Q2 earnings beat (Reuters)
• Biogen signals Leqembi sales gaining momentum, lifts profit forecast (Reuters)

• 6 burning questions about the White House health tech pledge (STAT)
• Sword moves beyond digital physical therapy (Endpoints)
• Dexcom raises sales expectations, discusses G8 plans (MedTech Dive)
• Trump administration launches health data sharing initiative (MedTech Dive)
• GE HealthCare projects reduced tariff expense (MedTech Dive)
• Biostate AI Builds Global RNA-AI Pipeline With $12M Boost, Ventures In China And India (MedTech Insight)

• Trump’s Brazil Tariffs Upend Crop Prices From Coffee to Juice (Bloomberg)
• Chobani sued by Danone for allegedly copying cold brew packaging (Food Dive)

• Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray (STAT)
• Researchers sequence complex parts of human genome, expanding the future of precision medicine (STAT)
• Warren questions HHS general counsel nominee about vaccines, abortion (The Hill)
• Cooper’s North Carolina Senate bid will put Medicaid front and center (The Hill)
• The Vaccine Injury Compensation Program needs to be updated, not eliminated (STAT)
• A Tip of the Hat to Retiring DEA Chief ALJ Mulrooney (FDA Law Blog)